Figure 1. hCD47/hPDL1 expression in wild-type MC38 and MC38-hCD47/hPDL1 cell lines.
Figure 2. Tumor growth curve of MC38-hCD47/hPDL1 syngeneic model (n=4).
Figure 3. The expression of hCD47/hPDL1 in humanized modified tumors by FACS.
Figure 4. Antitumor activity of Bispecific-antibody in two different treatment group (n=6).
Please fill in the order form and we will contact you within 2 working days.
